A Trial of SHR-1314 Injection in Adult Patients With Active Non-radiographic Axial Spondyloarthritis

NCT06860750 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

380

Enrollment

INDUSTRY

Sponsor class

Conditions

Active Non-radiographic Axial Spondyloarthritis

Interventions

DRUG: SHR-1314 Injection
DRUG: SHR-1314 Placebo Injection

Sponsor

Suzhou Suncadia Biopharmaceuticals Co., Ltd.